Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
To compare the relative effectiveness of the Imprimis Dropless™ (TriMoxiVanc) intraocular
solution with the Less Drops™ topical formulation of PredMoxiKeterolac (given for the first
week post op) followed by PredKeterolac (given for weeks 2 to 4 after surgery).
The hypothesis is that the "dropless" regimen will be non-inferior to the "less drops"
regimen in terms of post-operative IOP changes, post-operative healing, and visual quality.